Literature DB >> 21871657

Management of an acute outbreak of diarrhoea-associated haemolytic uraemic syndrome with early plasma exchange in adults from southern Denmark: an observational study.

Edin Colic1, Hans Dieperink, Kjell Titlestad, Martin Tepel.   

Abstract

BACKGROUND: Diarrhoea-associated haemolytic uraemic syndrome in adults is a life-threatening, but rare multisystem disorder that is characterised by acute haemolytic anaemia, thrombocytopenia, and renal insufficiency. We aimed to assess the success of management of this disorder with plasma exchange therapy.
METHODS: Patients diagnosed with diarrhoea-associated haemolytic uraemic syndrome in southern Denmark were treated with daily plasma exchange by centrifugation and substitution with fresh frozen plasma. Stool culture and serological testing was done to identify the cause of disease, and the success of management with plasma exchange therapy was assessed from change in platelet count, glomerular filtration rate, and lactate dehydrogenase.
FINDINGS: During May 25-28, 2011, five patients with a median age of 62 years (range 44-70) presented with diarrhoea-associated haemolytic uraemic syndrome, which was caused by an unusual Shiga-toxin-producing Escherichia coli serotype O104:H4. Strains of E coli showed a high resistance to third-generation cephalosporins because the strains had extended-spectrum β lactamases. After plasma exchange, median platelet count and glomerular filtration rate increased, median lactate dehydrogenase concentration decreased, and neurological status improved. The time interval from onset of bloody diarrhoea to start of plasma exchange had an inverse correlation with reduction of lactate dehydrogenase concentrations by plasma exchange (p=0.02). All patients were discharged with normal neurological status at 7 days (range 5-8) after starting plasma exchange.
INTERPRETATION: Early plasma exchange might ameliorate the course of diarrhoea-associated haemolytic uraemic syndrome in adults. However, this finding should be verified in randomised controlled trials FUNDING: None.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21871657     DOI: 10.1016/S0140-6736(11)61145-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  36 in total

Review 1.  Shiga toxin-associated hemolytic uremic syndrome: advances in pathogenesis and therapeutics.

Authors:  Tania N Petruzziello-Pellegrini; Philip A Marsden
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-07       Impact factor: 2.894

2.  Therapy: Early plasma exchange may be beneficial in diarrhea-associated hemolytic uremic syndrome.

Authors:  Claire Greenhill
Journal:  Nat Rev Nephrol       Date:  2011-09-27       Impact factor: 28.314

3.  Clinical characteristics and long-term outcome of diarrhea-associated hemolytic uremic syndrome: a single center experience.

Authors:  Takeshi Ninchoji; Kandai Nozu; Keita Nakanishi; Tomoko Horinouchi; Junya Fujimura; Tomohiko Yamamura; Shogo Minamikawa; Shingo Ishimori; Koichi Nakanishi; Norishige Yoshikawa; Ichiro Morioka; Hiroshi Kaito; Kazumoto Iijima
Journal:  Clin Exp Nephrol       Date:  2017-01-10       Impact factor: 2.801

4.  Diffusion-weighted imaging of the kidneys in haemolytic uraemic syndrome.

Authors:  Jochen Herrmann; Ulrich Wenzel; Stephanie Galler; Bjoern P Schoennagel; Jasmin D Busch; Magdalini Tozakidou; Kay U Petersen; Michaela Joekel; Peter Bannas; Jin Yamamura; Michael Groth; Gerhard Adam; Christian R Habermann
Journal:  Eur Radiol       Date:  2017-05-12       Impact factor: 5.315

Review 5.  Shiga toxin-producing Escherichia coli O104:H4: an emerging pathogen with enhanced virulence.

Authors:  Dakshina M Jandhyala; Vijay Vanguri; Erik J Boll; Yushuan Lai; Beth A McCormick; John M Leong
Journal:  Infect Dis Clin North Am       Date:  2013-07-24       Impact factor: 5.982

6.  Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy?

Authors:  Sonata Jodele; Benjamin L Laskin; Jens Goebel; Jane C Khoury; Susan L Pinkard; Patricia M Carey; Stella M Davies
Journal:  Transfusion       Date:  2012-07-15       Impact factor: 3.157

Review 7.  Guidelines for the management and investigation of hemolytic uremic syndrome.

Authors:  Takashi Igarashi; Shuichi Ito; Mayumi Sako; Akihiko Saitoh; Hiroshi Hataya; Masashi Mizuguchi; Tsuneo Morishima; Kenji Ohnishi; Naohisa Kawamura; Hirotsugu Kitayama; Akira Ashida; Shinya Kaname; Hiromichi Taneichi; Julian Tang; Makoto Ohnishi
Journal:  Clin Exp Nephrol       Date:  2014-08       Impact factor: 2.801

8.  Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain.

Authors:  Martina Bielaszewska; Evgeny A Idelevich; Wenlan Zhang; Andreas Bauwens; Frieder Schaumburg; Alexander Mellmann; Georg Peters; Helge Karch
Journal:  Antimicrob Agents Chemother       Date:  2012-03-05       Impact factor: 5.191

Review 9.  HUS and TTP in Children.

Authors:  Howard Trachtman
Journal:  Pediatr Clin North Am       Date:  2013-12       Impact factor: 3.278

10.  Diarrhea-associated hemolytic uremic syndrome with severe neurological manifestations treated with IgG depletion through immunoadsorption.

Authors:  Benjamin Flam; Peter Sackey; Andreas Berge; Anne C Zachau; Bo Brink; Sigrid Lundberg
Journal:  J Nephrol       Date:  2016-03-19       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.